We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Dog Genome Findings May Benefit Human Health

By Biotechdaily staff writers
Posted on 26 May 2004
Scientists studying the genetic background of dogs, which has revealed more than 150 inherited canine disorders resembling specific human diseases, say their work will provide information that can be used to improve human health.

The study, published in the May 21, 2004, issue of Science, has revealed distinct DNA blueprints for each of the 85 varieties of purebreds analyzed. More...
The researchers expect that understanding these genetic relationships will help them uncover the genes responsible for the physical features and behaviors unique to each breed as well as the diseases to which they are commonly susceptible, such as cancer, deafness, blindness, heart disease, and hip dysplasia.

"This study helps us understand the genetic relationship between breeds, a finding that will facilitate our efforts to map disease genes and genes for what are known as complex traits, which result from the interaction of multiple genes,” said Dr. Elaine Ostrander, of the Fred Hutchinson Cancer Research Center (Seattle, WA, USA; www.fhcrc.org), who is head of the dog genome project there.

Since any traits associated with a given breed must result from a shared set of genetic determinants, these genes stand out much more obviously than they would in a population of unrelated, or genetically dissimilar, animals. Since most breeds were developed within the last 300 years, the researchers expect that each distinctive trait has arisen from a small number of genes. These features make it easier to identify a gene or genes responsible for a specific trait.

"There are more than 400 breeds of dog, and each is an isolated breeding population,” remarked Dr. Ostrander. "What that means is that each dog breed is like a little Iceland, an isolated population that allows us to simplify a complicated genetic problem.”

To analyze the similarities and differences among purebred dogs, researchers contracted breed clubs and collected DNA samples from five animals from each of 85 breeds. They then genotyped the DNA, using microsatellite analysis. They found that the DNA sequences of microsatellites from dogs within a breed were much more similar than those among breeds.

They were able to sort the breeds into four groups of genetically similar varieties. One group represents an ancient group of animals with Asian and African origins that includes breeds such as the Alaskan Malamute and Siberian Husky, and shows the closest relationship to the wolf. A second group contains Mastiff-like breeds that share common physical characteristics. A third group includes Shetland and Belgian sheepdogs and Collies. The fourth group includes animals with hunting-associated behaviors.

The researchers are now using the information from their analysis to study specific canine diseases. In addition to cancer, they are studying the genetics of blindness and soon will begin a study on the genetics of obsessive-compulsive disease.

"We could not have done the work without the involvement of pet owners, breeders, and community leaders who support the work we're doing to improve both canine and human health. This is just the way science is supposed to be done,” said Dr. Ostrander.


Related Links:
Fred Hutchinson Cancer Center

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.